As of Feb 23
| +0.05 / +3.23%|
The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 16.50, with a high estimate of 16.50 and a low estimate of 16.50. The median estimate represents a +931.25% increase from the last price of 1.60.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.